Results 111 to 120 of about 553 (178)

Experiences of stigmatization and its impacts among individuals living with hereditary diseases and family members in Portugal: an exploratory study. [PDF]

J Community Genet
Valentim J, Paneque M, Mendes Á.
europepmc   +1 more source

Discrimination of benign, atypical, and malignant peripheral nerve sheath tumours in neurofibromatosis type 1 - intraindividual comparison of positron emission computed tomography and diffusion-weighted magnetic resonance imaging. [PDF]

EJNMMI Res
Ristow I, Apostolova I, Kaul MG, Stark M, Zapf A, Schmalhofer ML, Mautner VF, Farschtschi S, Adam G, Bannas P, Salamon J, Well L.   +11 more
europepmc   +1 more source

Atypical Multifocal Granular Cell Tumor with FLT3 Y842C Somatic Mutation: A case report and a review of the literature. [PDF]

Tunis Med
Zara Rozalen A, Garcia R, Husami S, Marino G, Nava VE.   +4 more
europepmc   +1 more source

The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis. [PDF]

Lancet Oncol
Groff KJ, Patel RV, Feng Y, Ghosh HS, Millares Chavez MA, O'Brien J, Chen WC, Nitturi V, Save AV, Youngblood MW, Horbinski CM, Chandler JP, Ehret F, Gui C, Wang JZ, Park K, Ajmera S, Rosenblum M, Suwala AK, Kresbach C, Mount CW, Schüller U, Santagata S, Sahm F, Bale TA, Jackson C, Richardson TE, Cai C, Nassiri F, Zadeh G, Kaul D, Capper D, Magill ST, Golfinos JG, Sen C, Patel AJ, Raleigh DR, Moliterno J, Pacione D, Snuderl M, Bi WL.   +40 more
europepmc   +1 more source

[Precocious puberty in the McCune-Albright Syndrome: a case report]. [PDF]

Pan Afr Med J
Rifai K, El Moatamid K, Iraqi H, Talbi D, Gharbi MEH.   +4 more
europepmc   +1 more source

Neurofibromatosis type 1 adult surveillance form for Austria. [PDF]

Wien Klin Wochenschr
Sunder-Plassmann V, Azizi AA, Farschtschi S, Gruber R, Hutterer M, Ladurner V, Röhl C, Welponer T, Bergmeister-Berghoff AS.   +8 more
europepmc   +1 more source

[Cancer in people with an intellectual disability in Germany: prevalence, genetics, and care situation]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Sappok T, Kowalski C, Zenker M, Weißinger F, Berger AW.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neurofibromatoses

Hematology/Oncology Clinics of North America, 2022
The neurofibromatoses are a group of genetic disorders that cause development of nervous system tumors as well as various other tumor and systemic manifestations. Neurofibromatosis type 1 is the most prevalent of these conditions and has the most variable phenotype and highest risk of malignant tumor formation.
Justin T, Jordan, Scott R, Plotkin
openaire   +2 more sources

Neurofibromatose

Neurologie up2date, 2022
Die Symptome einer Neurofibromatose können in allen Altersklassen erstmals auftreten, häufig bereits in den ersten 3 Lebensdekaden, teilweise mit sehr langsamer Entwicklung über Jahrzehnte oder rasch progredient innerhalb weniger Monate. Unter anderem diese unterschiedliche
Cordula Matthies, Eva Rampeltshammer, Maria Breun   +2 more
openaire   +1 more source